A study of the cerebral effect of pegylated interferon [peginterferon alfa 2b] in hepatitis C positive subjects
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 21 Jul 2006 The expected completion date for this trial is now 1 Dec 2006.
- 21 Jul 2006 New trial record.